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Abstract
Purpose: In our study, we aimed to show the efficiency of diffusion-weighted images at different b-values and apparent 
diffusion coefficient (ADC) values in the differentiation of recurrent tumours from post-treatment tissue changes.  
Material and methods: The conventional and diffusion magnetic resonance images (MRIs) of 42 patients operated for 
soft tissue sarcomas between June 2012 and March 2015 followed up with MRIs that were evaluated by 2 radiologists 
retrospectively. Diffusion MRIs were acquired at 4 different b-values (50, 400, 800, 1000 s/mm2). The lesions were 
classified according to conventional MRI findings as post-treatment changes and recurrent tumours.  
Results: When the patient group with recurrent tumours was compared with the patient group with postoperative 
changes the ADC calculations were statistically significantly lower for the recurrent tumours at all b-levels (p < 0.001 
for all b-levels). The sensitivity of b-50 values lower than 3.01 × 103 mm²/s in showing recurrent tumours was 100% 
and the specificity was 77.78%. The sensitivity of b-400 values lower than 2.1 × 103 mm²/s in showing recurrent tu-
mours was 80% and the specificity was 96.3%. The sensitivity of b-800 values lower than 2.26 × 103 mm²/s in showing 
recurrent tumours was 100% and the specificity was 88.89%. The sensitivity of b-1000 values lower than 2 × 103 mm²/s 
in showing recurrent tumours was 93.3% and the specificity was 92.5%.
Conclusions: The ADC values obtained from diffusion-weighted images have high sensitivity and specificity in differ-
entiating recurring soft tissue sarcomas during monitoring after treatment from postoperative changes. 
Key words: MR imaging, diffusion-weighted magnetic resonance imaging, soft tissue tumours, recurrent sarcomas, 
posttreatment changes.
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Introduction
Soft tissue sarcomas account for less than 1% of all adult 
malignancies [1,2]. Despite combined and aggressive 
treatment methods, including radiotherapy, chemother-
apy, and surgical treatment, local relapse rates of soft 
tissue sarcomas are between 5 and 35% [2]. Most relaps-
es develop within the first 2 years after surgery [3]. For 
this reason, postoperative follow-up must be done every 
36 months with imaging. The lesion size, location, histo-
logical grade, surgical resection efficiency, and response 
to adjuvant treatments are important risk factors for the 
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development of local recurrence [2]. Benign changes like 
haematoma, seroma, fibrosis, and granulation tissue that 
develop in the operation lodge after surgical treatment 
and radiotherapy may confuse local recurrence on mag-
netic resonance image (MRI) scans. In cases where a defi-
nite differentiation is not possible, the clinical approach 
is MRI follow-up or evaluation with positron emission 
tomography [4-6]. Diffusion MRI is currently routinely 
used in radiology clinics to identify fibrosis and tumours; 
it is a non-invasive method that generates contrasted im-
ages of the molecular movement of water. The diffusion 
sensitivity may vary at different b-values of diffusion. Im-
ages with low b-values are less diffusion weighted and use 
lower gradients. The diffusion sensitivity is also affected 
by perfusion at low b-values. Higher b-value images are 
more diffusion weighted and have low signal-to-noise ra-
tios. For a meaningful evaluation of diffusion MRIs, they 
must be obtained with at least 2 separate b-values. Mis-
takes in apparent diffusion coefficient (ADC) calculations 
can be prevented by obtaining more than one b-value 
[7,8]. There is no common consensus about the b-value 
and the number of different b-values required to be used 
in the MRI evaluations of the muscular-skeletal system. 
In our study, we aimed to show the efficacy of diffu-
sion-weighted images at different b-levels and ADC values 
in the differentiation of recurrent and residual tumours.
Material and methods
Patient selection
Fifty-six patients who had undergone surgery with the 
diagnosis of soft tissue sarcomas between June 2012 and 
March 2015 that were followed-up with MRIs were evalu-
ated. After the surgery, 5 patients with positive surgical 
margins and residual disease, 5 patients with detected 
lung metastases, and 2 patients with a history of a second 
primary cancer (one was colon cancer, the other was pap-
illary thyroid cancer) were excluded from the trial. In ad-
dition, 2 patients with a groin localized tumour and a hip 
prosthesis were excluded from the trial to avoid artifacts. 
Forty-two patients who underwent extensive resection 
and had clean surgical margins, who attended their MRI 
follow-ups at month 6 and later were included in the trial. 
The study was approved by our institutional review board, 
and all patients gave their informed consent. The patient 
MRIs were re-evaluated and compared to the results of 
the histopathological evaluation of the surgical specimens. 
The demographic data and clinical findings of the patients 
were accessed using the patient archive system.
Magnetic resonance imaging acquisition
All MRI examinations were performed on a 1.5T MR 
system (Signa Excite HD, GE Healthcare) with differ-
ent coils for knee, shoulder, and body. Axial and coronal 
T1-weighted (spin-echo imaging, repetition time ms/
echo time ms = 580-700/9.4-28.3) and fluid sensitive 
(short tau inversion recovery imaging: 1500-5000/15-142; 
T2 weighted imaging: 3500-5700/15-170) sequences, 
as well as T1-weighted sequences (480/7.6-22.9), 8/1.5 
mm thick sections after intravenous administration of 
contrast material (gadopentetate dimeglumine [Magn-
evist# Bayer Schering, Berlin, Germany], 0.1 mmol/kg 
body weight), were performed in all patients. DWI was 
performed using an axial single-shot echoplanar imag-
ing sequence centred on the lesions (b = 50, 400, 800, 
and 1000 s/mm²; 1800/93.8; echo train length, 2; band-
width, 31.25 MHz; matrix size, 160 × 192; field of view, 
20-35 mm; number of signals averaged, 4; number of 
slices, 10; slice thickness, 7 mm; intersection gap, 1 mm; 
acquisition time, 2:53 minutes each for the four b-values).
Magnetic resonance imaging analysis and data collection
All images were transferred to a workstation (Advantage 
Windows version 4.2_07, GE Healthcare) and the DWI 
sequence was post-processed with commercial software 
(FuncTool, GE Healthcare) to obtain ADC maps (black/
white and colour, the latter with a Puh-thallium colour 
scheme, ranging from black, diffusion restriction, to red, 
no diffusion restriction). The ADC maps of each lesion 
were calculated using four b-values (50, 400, 800, and 
1000 s/mm²). The scanner software provided the mean 
value within the ROI, which equaled the ADC value (mul-
tiplied by 10-3). 
The MRI findings were re-evaluated by radiologists 
with 8 years of experience (BS) and 10 years of experience 
(EA) in musculoskeletal MRI, respectively. The signal 
chara cteristics, contrast enhancement patterns, locoregion-
al distribution of the postoperative tissue areas, and suspi-
cious lesions were evaluated. The haematoma, seroma, and 
areas of postsurgical or postradiotherapy soft tissue chang-
es and the masses that may relapse were identified based 
on the study by Garner et al. according to the T1, T2, and 
contrasting patterns observed in the patients [6]. Lesions 
hyperintense in T1-weighted and T2-weighted images 
that did not demonstrate significant contrast enhance-
ment following IV contrast administration were classified 
as haematoma (Figure 1A-D); lesions with hypointense 
signal characteristics in T1-weighted images and hyper-
intense in T2-weighted images that did not enhance with 
contrast after IV contrast administration or contrasted 
peripherally were classified as seroma (Figure 1E-H); 
areas with hypointense signal characteristics in T1-weight-
ed images and hyperintense in T2-weighted images that 
were mildly enhanced with contrast after IV contrast ad-
ministration were classified as changes after operation 
and radiotherapy (Figure 1I-L); and lesions that were T1 
hypointense, T2 hyperintense, and enhanced with con-
trast after IV contrast administration were classified as po-
tential recurrent masses (Figure 1M-P, Figure 2, Table 1). 
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In diffusion-weighted images, 1 cm² ROIs were placed 
in postoperative tissue areas with hyperintense areas in 
T2-weighted images and 3 different areas with an appear-
ance suspicious of recurrent masses, and the mean ADC 
values were calculated. ADC calculation was not done in 
the hypointense areas in T1-T2-weighted images and were 
considered as fibrosis. After MRI examinations, biopsies 
were obtained from the suspicious lesions with wire local-
ization biopsies in 2 patients, and 13 patients underwent 
total excision. The mean diameter of the lesions excised was 
measured as 4.3 ± 1.5 cm (range 2-8 cm). Patients regard-
ed as post-treatment tissue changes according to the T1, 
T2, and contrasting characteristics were followed up for 
a mean period of 17.8 ± 6.7 months (range, 8-32 months). 
Figure 1. The magnetic resonance imaging (MRI) obtained at month 12 of the 48-year-old male patient operated with the diagnosis of liposarcoma in the 
thigh the lesion (A) hyperintense in T1-weighted images and (B) with hyperintense signal characteristics in T2-weighted images and (C) that did not demon-
strate increased contrast enhancement after IV contrast administration was regarded as a haematoma (D). It was hyperintense in the diffusion weighted 
images, and the apparent diffusion coefficient (ADC) value was calculated as 2.5 × 10-3 mm²/s in the ADC map (E-H). In the MRI of the 64-year-old female 
patient operated on with the diagnosis of a fibrosarcomas in the groin obtained at 8 months after surgery the lesion (E) with hypointense signal characteri-
stics in T1-weighted images and (F) hyperintense in T2-weighted images and (G) that enhanced with contrast peripherally after IV contrast administration 
was regarded as a seroma (H) was hyperintense in diffusion weighted images and the ADC value was calculated as 3 × 10-3 mm²/s in the ADC map (I-L). 
In the elbow MRI obtained at the month 24 follow-up of a 42-year-old male patient operated because of a synovial sarcoma located in the antecubital area 
the areas (I) with hypointense signal characteristics and (J) hyperintense in T2-weighted images and (K) enhancing with contrast mildly after IV contrast 
administration were evaluated as post-treatment changes and (L) were hyperintense in diffusion-weighted images, and the ADC value was calculated as 
2.8 × 10-3 mm²/s in the ADC map (M-P). In the MRI follow up of a 34-year-old patient operated for a fibrosarcoma located in the superior of the shoulder 
obtained at month 12 after surgery the lesions (M) hypointense in T1-weighted images (N) hyperintense in T2-weighted images and (O) enhancing with 
contrast after IV contrast administration were primarily evaluated as recurrent masses and (P) were hyperintense in diffusion-weighted images, and the 
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Figure 2. In month 12 magnetic resonance imaging (MRI) follow-up of a 67-year-old patient operated for a liposarcoma located in the proximal of the 
groin the lesions (A) hypointense in T1-weighted images, (B) hyperintense in T2-weighted images and (C) that enhanced with contrast after IV contrast 
administration were primarily regarded as recurrent masses and (D) were hyperintense in diffusion weighted images and the ADC value was calculated as 
1.3 × 10-3 mm²/s in the apparent diffusion coefficient (ADC) map
Table 1. Magnetic resonance imaging findings after treatment of soft-tissue sarcomas
  T1 WI T2 WI CE DWI
Haematoma Hypo-hyperintense¹ Hypo-hyperintense¹ No contrast Hyper-hypointense¹
Seroma Hypointense Hyperintense No contrast or contrasted peripherally Hyperintense
Post-treatment fibrous changes Hypointense Hyperintense Mildly enhanced Hypointense
Recurrent mass Hypointense Hyperintense Enhanced Hyperintense
¹Age dependent 
No relapse or change in the tissue areas was iden tified during 
follow-up. 
Pathology
One patient underwent surgery for an alveolar rhabdo-
myosarcoma, 1 for embryonal rhabdomyosarcoma, 8 for 
fibrosarcomas, 6 for leiomyosarcomas, 8 for pleomorphic 
liposarcomas, 6 for myxoid liposarcomas, 2 for angiosar-
comas, 1 for a malign schwannoma, 4 for pleomorphic 
sarcomas, 1 for a myxofibrosarcoma, 3 for synovial sar-
comas, and 1 for soft tissue osteosarcoma. Among the 
tumours that relapsed, 1 was an alveolar rhabdomyosar-
coma, 3 were fibrosarcomas, 2 were leiomyosarcomas, 
3 were pleomorphic liposarcomas, 1 was a myxoid liposar-
coma, 2 were angiosarcomas, 1 was a malignant schwan-
noma, 1 was a synovial sarcoma, and 1 was soft tissue 
osteosarcoma. Five (11.9%) of the sarcomas were grade 1, 
21 (50%) were grade 2, and 16 (38.1%) were grade 3.
Statistical analysis
Descriptive statistics were expressed as mean ± standard 
deviation for continuous variables, and count and percent-
age for categorical variables. A c2 test was used to com-
pare differences between groups for categorical variables. 
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Repeated measures ANOVA was performed to compare 
means of different b-values (50, 400, 800, 1000). A post 
hoc Bonferroni test was used to examine multiple com-
parisons. The discriminatory performance of a quantita-
tive test (b-50, b-40, b-800, b-1000) was evaluated by re-
ceiver-operating characteristics (ROC) analysis. The ROC 
curve was plotted based on the true-positive rate (TPR) 
and the false-positive rate (FPR). The area under the ROC 
curve (AUC) was obtained using the parametric method 
(trapezoidal rule). Histopathology and MR follow-up was 
taken as the reference standard method. Areas under the 
ROC curves were compared for b-50, b-400, b-800, and 
b-1000. Results of statistical significance were provided 
after Bonferroni’s correction. After ROC analysis, the op-
timal cut-off point was determined according to the Youd-
en index. Sensitivity, specificity, positive predictive value 
(PPV), and negative predictive value (NPV) for b-values 
were calculated according to the optimal cut-off point. 
P < 0.05 was accepted as statistically significant. All statis-
tical analyses were performed by using IBM SPS Statistics 
21.0 software.
Results
Recurrent tumours were identified in 15 of the 42 patients 
included in the study. Out of these patients, 6 (40%) were 
female and 9 (60%) were male. Out of the 27 patients clas-
sified as postoperative tissue changes, 14 (51.8%) were fe-
male and 12 (48.1%) were male. There was no statistical 
difference with respect to gender between the 2 groups 
(p = 0.183). The mean age of patients with recurrent tu-
mours identified was 51.6 ± 19.5 years, and the mean age 
of patients with postoperative tissue changes was 51.07 
± 1.37 years. No significant difference was identified be-
tween the groups with respect to age (p = 0.909) (Table 2). 
No statistical difference was present between the tumour 
types with respect to the ADC calculations at all b-levels. 
There was no meaningful correlation between the histo-
pathological grade and ADC values. Twenty-two of the 
tumours were located in the thigh. Of the other tumours, 
5 were in the leg, 3 in the popliteal fossa, 3 in the fore-
arm, 2 neighbouring the knee, 2 in the shoulder, 2 in the 
arm, 1 in the antecubital fossa, 1 neighbouring the hip, 
and 1 in the elbow. Among the lesions considered as post-
treatment tissue changes, 4 were fluid collections; 3 were 
postoperative haematoma. The other 18 lesions were T1 
hypointense and T2 hyperintense and enhanced minimal-
ly following IV contrast administration.
When the group of recurrent tumour patients was com-
pared to the postoperative changes group, the ADC calcu-
lations were statistically significantly lower at all b-levels 
(p < 0.001) (Table 2). The ADC values of recurrent tu-
mours, areas of postoperative tissue change, and adjacent 
healthy muscular tissues measured at different b-values are 
summarized in Table 2. The sensitivity of b-50 values low-
er than 3.01 × 10-3 mm²/s in showing recurrent tumours 
was 100% and the specificity was 77.78%. The sensitivity 
of b-400 values lower than 2.1 × 10-3 mm²/s in showing 
recurrent tumours was 80% and the specificity was 96.3%. 
The sensitivity of b-800 values lower than 2.26 × 10-3 mm²/s 
in showing recurrent tumours was 100% and the specifici-
ty was 88.89%. The sensitivity of b-1000 values lower than 
2.05 × 10-3 mm²/s in showing recurrent tumours was 93.3% 
and the specificity was 92.5% (Table 3, Figure 3). No sig-
nificant difference was identified among the b-50, b-400, 
b-800, and b-1000 values in differentiating tumour recur-
rence from the postoperative changes (p = 0.91 for b-50 
and b-400, p = 0.28 for b-50-800, p = 0.79 for b-50-1000, 
p = 0.12 for b-400-800, p = 0.80 for b-400-1000, p = 0.31 
for b-800-1000, significant after Bonferroni’s correction 
p < 0.00833).
Discussion
Our study identified that the ADC calculations obtained 
from diffusion-weighted images at different b-levels are 
highly sensitive and specific in the differentiation of soft tis-
sue sarcoma recurrence and postoperative benign changes.
Table 3. Area under the receiver operating characteristics curve (AUC) and 
criteria (apparent diffusion coefficient – ADC) observed to maximize sensi-
tivity and specificity for predicting recurrent tumour (n = 42) 







50 0.951 ≤ 3.01 100 77.78
400 0.947 ≤ 2.10 80 96.30
800 0.981 ≤ 2.26 100 88.89
1000 0.937 ≤ 2.00 93.33 92.59
Table 2. Comparison of demographic characteristics and apparent diffusion 










Age (year) 51.66 ± 19.5 51.07 ± 14.1 0.909
Gender, n (%) 
Female 6 (40) 14 (52) 0.342
Male 9 (60) 13 (48)
b-50 (× 10-3 mm²/s) 2.10 ± 0.57 3.28 ± 0.49 < 0.001
b-400 (× 10-3 mm²/s) 1.73 ± 0.52 3.02 ± 0.55 < 0.001
b-800 (× 10-3 mm²/s) 1.49 ± 0.54 2.90 ± 0.55 < 0.001
b-1000 (× 10-3 mm²/s) 1.44 ± 0.59 2.72 ± 0.57 < 0.001
Mean ADC value of adjacent 
tissue (× 10-3 mm²/s) 
2.66 ± 0.57 2.86 ± 0.72 < 0.350
P ≤ 0.05 was statistically significant 
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Conventional MRI plays an important role in the postop-
erative evaluation of soft tissue sarcomas. However, once pa-
tients are delivered radiotherapy and chemotherapy after sur-
gical treatment, differentiating areas of posttreatment tissue 
changes from tumour recurrence is sometimes difficult [2]. 
Postoperative seroma, haematoma, and inflammatory chang-
es following radiotherapy are hyperintense in T2-weighted 
sequences, and most tumour recurrences also appear hyper-
intense in T2-weighted sequences [9-12]. Vanel et al. showed 
that hypointense signal changes in T2-weighted images have 
a sensitivity of 96% in ruling out tumour recurrence and resi-
dues [11]. In addition, the preservation of the muscle tex-
ture sign finding in T1-weighted images can also be used to 
rule out tumours [13]. In dynamic evaluations, the areas of 
post-treatment tissue changes enhance with contrast in the 
later stage, and tumour recurrence enhances in earlier stages 
[14]. The sensitivity of dynamic evaluation has been reported 
as 87% and the positive predictive value as 70% [15]. Myxoid 
tumours can be confused with postoperative seroma because 
of their high signal intensities in T2-weighted images [16,17]. 
Tumours that contain high mineralization and fibrous com-
ponents may be confused with postoperative scar tissue [2]. 
Tumours with haemorrhagic components may be confused 
with postoperative haematomas. Therefore, the tumour re-
currence can be differentiated from post-treatment tissue 
changes to a limited extent in some tumours [10]. In cases 
where conventional methods fall short, and if contrast is 
not administered to the patient, new imaging methods are 
needed to differentiate recurrent tumours from postoperative 
tissue changes and to guide the surgery.
ADC mapping in diffusion MRI evaluations is used 
to demonstrate the levels of cellularity in different areas 
of the body. Diffusion-weighted images can be used to 
differentiate tumour recurrence from posttreatment soft 
tissue changes. Low ADC values are obtained in malign 
tumours with high cellularity, fibromuscular tissue, and 
fat tissue; high ADC levels are obtained from tumours 
with low cellularity, lesions with fluid content, necrot-
ic regions, and acellular regions [7,9]. Most of our pa-
tients included in the study had high-grade sarcomas 
that demonstrated high cellularity. However, we could 
not identify a meaningful correlation between the histo-
pathological grades and the ADC values. The ADC values 
of relapsed massive lesions were lower when compared 
to the areas of benign changes. When the ADC values 
of benign changes like haematoma, seroma, edema, and 
inflammatory changes that develop after treatment were 
compared with recurrent tumours, they were higher, and 
these results are consistent with the literature. Low ADC 
vwalues are obtained in the development of fibrous tissue 
change [18]. In the study conducted by Del Grande et al. 
it was shown that lower ADC values were obtained from 
fibrous tissue areas than the tumour tissues. This is why 
we did not perform calculations in the areas we regarded 
as fibrous tissue that had hypointense signal characteris-
tics in T1-T2 weighted images and did not enhance with 
contrast after IV contrast administration in our study. 
Baur et al. reported that ADC mapping can be used to 
identify sarcoma recurrence and that diffusion ADC 
mapping is effective in differentiating muscular edema 
and postoperative seroma from recurrent tumours [19]. 
In the study conducted by Grande et al., with a small 
number of patients, using a 3 tesla MRI, they found that 
the ADC values obtained from diffusion-weighted MRIs 
were statistically significantly different for recurrence, 
post operative scar tissue, and haematoma. They identified 
that the mean ADC for recurrence was 1.08 × 10-3 mm2/s, 
0.9 × 10-3 mm2/s for postoperative scar tissue, and 0.9 × 10-3 
mm2/s for haematoma [18]. We calculated the mean ADC 
value of relapsed masses as 1.69 × 10-3 mm²/s and as 2.98 × 10-3 
mm²/s for areas of post-treatment tissue changes. Because 
we did not measure the ADC values of fibrous tissues in 
our study, we may have calculated a higher ADC value 
for post-treatment changes than the ADC value calculated 
by Grande et al. for postoperative scar tissue. When the 
tumours in our study were evaluated according to the his-
tological subtypes, it was seen that 2 angiosarcomas had 
higher ADC values than the other soft tissue sarcoma re-
currences (mean 2.7 × 10-3 mm²/s). The ADCs obtained 
might be higher because of the different histological con-
tent of angiosarcomas like haemorrhages.
The role of different b-values in showing soft tissue 
sarcomas and sarcoma recurrences has not been inves-
tigated before [18,20]. Different b-values can change the 
sensitivity of the diffusion. At lower b-values, a signal de-
crease may occur in water molecules that have high levels 
of motion similar to intravascular space. This is why ADC 
is significantly affected by vascular perfusion. At high 
b-values, the signal-to-noise ratio decreases, which also 
affects ADC calculations [19-24]. Due to this, to obtain 
accurate ADC values, calculations must be done with at 
least 3 different b-values [20]. We performed 4 different 
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ADC calculations in our study. The mean ADC calcula-
tions at b-values of 50 (2.10 × 10-3 ± 0.57, p < 0.01) were 
higher when compared to other b-values, but we found 
meaningful results in showing recurrence just as in other 
b-values. We found that all b-values had high sensitivity 
and specificity and identified that the sensitivity and spec-
ificity were highest at b-1000 values. To avoid artifacts, it 
may be sufficient to shorten the duration and carry out 
evaluations at 2 different b-values. 
Because the signal-to-noise ratio is lower in diffusion- 
weighted images, more artifacts may be present, especially 
in the postoperative period, compared to conventional se-
quences [19,20]. We did not include patients who had pros-
theses or operation material that cause artifacts in the study.
Our study had some limitations. Our study was retro-
spective, and we worked with a heterogeneous patient group. 
Because the tumours were located in different areas of the 
body, the imaging protocols differed accordingly. Because 
we used 4 different b-values, the imaging duration was pro-
longed, and movement artifacts were more common.
Another limitation was the number of patients. Both 
the overall number of patients and the number of relapse 
patients were low (15/40). Further research, with more 
patients, directed to the ADC evaluation of specific sarco-
ma diagnoses and research that evaluates the ADC calcu-
lations of benign neoplasias like low-grade tumours and 
fibromatosis that have high recurrence rates are necessary.
Conclusions
The ADC values obtained from diffusion-weighted images 
have high sensitivity and specificity in differentiating re-
curring soft tissue sarcomas during monitoring after treat-
ment from postoperative changes. The highest sensitivity 
and specificity were obtained at the b-1000 level.
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